Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

BioMark Diagnostics Inc. is a liquid biopsy company. The Company is developing a molecular diagnostics technology platform, which leverages the power of metabolomics and machine learning algorithms to bring new cancer diagnostics to market and improve cancer prognosis by allowing physicians to detect carcinomas in the pre-symptomatic stages. The technology can also be used for measuring... see more

Recent & Breaking News (CSE:BUX)

BioMark Diagnostics to Present at Rodman & Renshaw Global Investment Conference

GlobeNewswire September 3, 2015

BioMark Diagnostics Announces Progress in Assay Validation for Clinical Sample Analysis

GlobeNewswire August 19, 2015

BioMark Diagnostics Announces Progress in Assay Validation for Clinical Sample Analysis

Marketwired August 19, 2015

BioMark Diagnostics Unveils U.S. Strategy

GlobeNewswire August 13, 2015

BioMark Appoints Dr. Thomas Malcolm to Lead U.S. Operations

GlobeNewswire August 11, 2015

BioMark Diagnostics-Sponsored Project Receives NSERC Engage Grant

GlobeNewswire July 29, 2015

BioMark Diagnostics-Sponsored Project Receives NSERC Engage Grant

Filing Services Canada July 29, 2015

BioMark Diagnostics-Sponsored Project Receives NSERC Engage Grant

Filing Services Canada July 29, 2015

BioMark Diagnostics Engages LHA for Investors Relations

Filing Services Canada June 29, 2015

BioMark Secures DTC Eligibility

Filing Services Canada May 28, 2015

BioMark Receives No Objection Letter from Health Canada

Filing Services Canada May 26, 2015

BIOMARK's Clinical Technology Center at Innovation Boulevard in Surrey BC

Filing Services Canada April 27, 2015

BioMark Presents at 11th Annual Conference of the Metabolomics Society

Filing Services Canada April 14, 2015

BioMark Receives NSERC Engage Grant for Raman Enhancement with Dr.  Safieddin Safavi-Naeini

Filing Services Canada April 7, 2015

BioMark Receives BIAP funding from NRC-IRAP

Filing Services Canada March 31, 2015

BioMark Announces Partnership with the Metabolomics Innovation Centre

Filing Services Canada March 27, 2015

BioMark Added to CSE Composite Index

Filing Services Canada March 25, 2015

New Cancer Diagnostic Primed to Change the Industry

Accesswire March 5, 2015

BioMark Announces Grant Funded Partnership With TMIC

Filing Services Canada March 2, 2015

BioMark Announces a Final Closing Private Placement

Filing Services Canada February 18, 2015